Nerai Biosciences
Pre-clinicalIntroducing Nerai, a Swiss biotech company engineering precise, next-gen genome editors to cure inherited diseases through innovative CRISPR technology.
Founded
2021
Focus
NeuroscienceAI / Machine Learning
About
Introducing Nerai, a Swiss biotech company engineering precise, next-gen genome editors to cure inherited diseases through innovative CRISPR technology.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedNov 15, 2021
Company Info
TypePrivate
Founded2021
LocationZurich, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile